Related Experiment Video
Updated: Aug 14, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Febrile episodes in children with sickle cell disease treated on an ambulatory basis
S S Bakshi1, R Grover, E Cabezon
1St. Luke's-Roosevelt Hospital Center, Department of Pediatrics, New York, NY 10025.
Insights
Ambulatory parenteral ceftriaxone is a safe and effective alternative for managing febrile children with sickle cell disease, significantly reducing hospitalization days and preventing sepsis.
Area of Science:
- Pediatrics
- Infectious Diseases
- Hematology
Background:
- Children with sickle cell disease (SCD) face a high risk of severe Streptococcus pneumoniae infections.
- Current standard care involves hospitalization and parenteral antibiotics for all febrile SCD patients.
Purpose of the Study:
- To evaluate the safety and effectiveness of ambulatory parenteral ceftriaxone in febrile children with SCD.
- To assess its potential to prevent sepsis and decrease hospitalization duration.
Main Methods:
- Selected febrile children with SCD were treated with ceftriaxone on an outpatient basis.
- Data on sepsis development and hospitalization days were compared to historical controls.
Main Results:
- Twenty out of 40 eligible children received ambulatory ceftriaxone; 3 required subsequent hospitalization.
- Hospitalization days decreased from 214 to 111 days compared to the previous year.
Conclusions:
- Empiric ambulatory ceftriaxone appears safe and effective for selected febrile SCD patients.
- Further expanded studies are needed to confirm these findings over a longer period.
Abstract:
Children with sickle cell disease have a greatly increased potential for developing rapid and at times fatal sepsis from Streptococcus pneumoniae. Hospitalization and parenteral antibiotic treatment in all febrile children with sickle cell disease have thus become the standard of care at most sickle cell centers. As an alternative approach, we managed selected febrile children with sickle cell disease on an ambulatory basis with parenteral ceftriaxone to determine its safety and effectiveness in preventing sepsis and reducing the number of days of hospitalization. Twenty of 40 children who presented with significant fever met the study criteria and received ceftriaxone on an ambulatory basis. Three were subsequently hospitalized. Compared with a previous year, when all febrile children were admitted, ceftriaxone use reduced the days of hospitalization from 214 (6.3 +/- 1.6 days/patient) to 111 days (2.8 +/- 0.7 days/patient). The empiric use of ceftriaxone appears safe and effective, but it requires an expanded study over an extended period.
Related Concept Videos
Increased Body Temperature
Methods of reducing fever
Pharmacological Methods of Reducing Fever:
Pulse rhythm
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac muscle...
Types of Fever
Here are the different types of fever:
Tonsillitis II: Management
Drug Dosing: Infants and Children
